Aktana equips life science companies with the decision support technology to quickly evaluate mountains of data, extracting only what’s relevant and valuable at the time of decision. With brand strategy as a starting point, Aktana analyzes market data, channel activity and HCP preference to provide life science companies with the insights, clarity and guidance to deliver the right information at the right time to physicians and their patients. In fact, nearly half of the world's top-20 pharmaceutical companies rely on Aktana to put complex data into context, coordinate channel activity and improve sales effectiveness by up to 30 percent.
Featured
Resources
View AllLatest Updates
Novartis and Aktana at Veeva Summit: Building the AI-Driven Commercial Engagement Model
We returned as a platinum sponsor once again to the Veeva Commercial and Medical Summit, which welcomed over 1,700 attendees in Philadelphia this year. At the event, Eva Martins, Global Head of Innovative Models and Commercial Transformation at Novartis, and Derek Choy, Co-founder and COO at Aktana, presented how Novartis is partnering with Aktana to […]
Read More